Skip to content
CancerIndex

Loading the knowledge graph…

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia — knowledge graph · CancerIndex